Cargando…
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
Normal living cells exhibit phosphatidylserine (PS) primarily within the intracellular leaflet of the plasma membrane. In contrast, viable cancer cells have high levels of PS on the external surface, and exhibit a broad range of surface PS, even within specific types of cancer. Agents that target su...
Autores principales: | Davis, Harold W., Vallabhapurapu, Subrahmanya D., Chu, Zhengtao, Vallabhapurapu, Swarajya L., Franco, Robert S., Mierzwa, Michelle, Kassing, William, Barrett, William L., Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368238/ https://www.ncbi.nlm.nih.gov/pubmed/30783515 http://dx.doi.org/10.18632/oncotarget.26615 |
Ejemplares similares
-
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020) -
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014) -
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
por: Sulaiman, Mahaboob K, et al.
Publicado: (2015) -
SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020) -
Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013)